This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2015 Mar;16(3):e105.

doi: 10.1016/S1470-2045(15)70096-3.

Correction to Lancet Oncol 2015; 16: 274

S Aluwini, F Pos, E Schimmel

PMID: 25752558
DOI: 10.1016/S1470-2045(15)70096-3

Published Erratum

Correction to Lancet Oncol 2015; 16: 274

S Aluwini et al. Lancet Oncol. 2015 Mar.

. 2015 Mar;16(3):e105.

doi: 10.1016/S1470-2045(15)70096-3.

Authors

S Aluwini, F Pos, E Schimmel

PMID: 25752558
DOI: 10.1016/S1470-2045(15)70096-3

No abstract available

PubMed Disclaimer

Erratum for

Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial.
Aluwini S, Pos F, Schimmel E, van Lin E, Krol S, van der Toorn PP, de Jager H, Dirkx M, Alemayehu WG, Heijmen B, Incrocci L. Aluwini S, et al. Lancet Oncol. 2015 Mar;16(3):274-83. doi: 10.1016/S1470-2045(14)70482-6. Epub 2015 Feb 3. Lancet Oncol. 2015. PMID: 25656287 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science